{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/07/3269004/0/en/NervGen-Pharma-Announces-Successful-End-of-Phase-2-Meeting-and-FDA-Alignment-on-RESTORE-a-Phase-3-Registrational-Study-of-NVG-291-for-Chronic-Tetraplegia.html", "message": "News view counter 650717 successfully enlarged"}